[1]
“The effectiveness of omalizumab in the control of severe uncontrolled asthma in Latin America. An exploratory systematic review and meta-analysis”, Rev Alerg Mex, vol. 67, no. 1, pp. 19–24, Jan. 2020, doi: 10.29262/ram.v67i1.701.